Advancing therapy for neuroblastoma

B Qiu, KK Matthay - Nature Reviews Clinical Oncology, 2022 - nature.com
Neuroblastomas are tumours of sympathetic origin, with a heterogeneous clinical course
ranging from localized or spontaneously regressing to widely metastatic disease …

Neuroblastoma heterogeneity, plasticity, and emerging therapies

KI Lundberg, D Treis, JI Johnsen - Current Oncology Reports, 2022 - Springer
Abstract Purpose of Review The evolving information of the initiation, tumor cell
heterogeneity, and plasticity of childhood neuroblastoma has opened up new perspectives …

Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma

K Helmsauer, ME Valieva, S Ali… - Nature …, 2020 - nature.com
MYCN amplification drives one in six cases of neuroblastoma. The supernumerary gene
copies are commonly found on highly rearranged, extrachromosomal circular DNA (ecDNA) …

Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma

C Thirant, A Peltier, S Durand, A Kramdi… - Nature …, 2023 - nature.com
Noradrenergic and mesenchymal identities have been characterized in neuroblastoma cell
lines according to their epigenetic landscapes and core regulatory circuitries. However, their …

IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression

S Hagemann, D Misiak, JL Bell, T Fuchs, MI Lederer… - Molecular Cancer, 2023 - Springer
Background Neuroblastoma is the most common solid tumor in infants accounting for
approximately 15% of all cancer-related deaths. Over 50% of high-risk neuroblastoma …

Neuroblastoma and the epigenome

IS Fetahu, S Taschner-Mandl - Cancer and Metastasis Reviews, 2021 - Springer
Neuroblastoma (NB) is a pediatric cancer of the sympathetic nervous system and one of the
most common solid tumors in infancy. Amplification of MYCN, copy number alterations …

SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry

B Decaesteker, A Louwagie, S Loontiens… - Nature …, 2023 - nature.com
The pediatric extra-cranial tumor neuroblastoma displays a low mutational burden while
recurrent copy number alterations are present in most high-risk cases. Here, we identify …

Targeting KDM4 for treating PAX3-FOXO1–driven alveolar rhabdomyosarcoma

S Singh, A Abu-Zaid, H Jin, J Fang, Q Wu… - Science translational …, 2022 - science.org
Chimeric transcription factors drive lineage-specific oncogenesis but are notoriously difficult
to target. Alveolar rhabdomyosarcoma (RMS) is an aggressive childhood soft tissue …

ARID1A loss in neuroblastoma promotes the adrenergic-to-mesenchymal transition by regulating enhancer-mediated gene expression

H Shi, T Tao, BJ Abraham, AD Durbin… - Science …, 2020 - science.org
Mutations in genes encoding SWI/SNF chromatin remodeling complexes are found in
approximately 20% of all human cancers, with ARID1A being the most frequently mutated …

An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability

Z Nagy, JA Seneviratne, M Kanikevich… - Nature …, 2021 - nature.com
To achieve the very high oncoprotein levels required to drive the malignant state cancer
cells utilise the ubiquitin proteasome system to upregulate transcription factor levels. Here …